DebX Medical: The Effectiveness of Debrichem on In Vitro Biofilms Report

All testing was performed in triplicate and testing was completed twice, separated by 2 weeks apart. This was to ensure reproducibility (Parker et al., 2018). Testing was undertaking in accordance with ASTM methods.

Download Debrichem Report

More Posts

Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK

Objective: To estimate whether the topical debriding agent, Debrichem, could potentially afford the UK’s National Health Service (NHS) a cost-effective intervention for the management of

SA Introduction Letter

“If biofilms keep chronic wounds from healing, then Debrichem® is the solution” It is with great pride and anticipation that Debx Africa (Pty) Ltd are

Licence To Manufacture In Terms Of Section 22c(1)(B)

This licence authorises manufacture by the licence holder named; if the business should change hands, the company or person taking over the business will have

Licence To Manufacture Medical Devices

The licence holder and the persons described and named in Annexure 1 shall at all times ensure that all medical devices distributed, irrespective of its

Case Report Form

Within one minute of topical application of a red gel intends to facilitate the removal of unhealthy tissue. The semi fluid substance containing an acid

DebX Medical: The Effectiveness of Debrichem on In Vitro Biofilms Report

More Posts

Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK

SA Introduction Letter

Licence To Manufacture In Terms Of Section 22c(1)(B)

Licence To Manufacture Medical Devices

Case Report Form

Get in touch

About us

Terms and Privacy

Downloads

welcome.

Login to get access to our case reports.

Login to your account